A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional
Errataetall: |
CommentOn: J Infect. 2022 Apr;84(4):542-550. - PMID 35085659 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
---|---|
Enthalten in: |
The Journal of infection - 85(2022), 1 vom: 25. Juli, Seite e15-e17 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pandit, Priyanka [VerfasserIn] |
---|
Links: |
---|
Themen: |
Breakthrough |
---|
Anmerkungen: |
Date Completed 14.06.2022 Date Revised 07.08.2022 published: Print-Electronic CommentOn: J Infect. 2022 Apr;84(4):542-550. - PMID 35085659 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2022.04.023 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM339764619 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM339764619 | ||
003 | DE-627 | ||
005 | 20231226003626.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2022.04.023 |2 doi | |
028 | 5 | 2 | |a pubmed24n1132.xml |
035 | |a (DE-627)NLM339764619 | ||
035 | |a (NLM)35447232 | ||
035 | |a (PII)S0163-4453(22)00205-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pandit, Priyanka |e verfasserin |4 aut | |
245 | 1 | 2 | |a A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.06.2022 | ||
500 | |a Date Revised 07.08.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: J Infect. 2022 Apr;84(4):542-550. - PMID 35085659 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Comment | |
650 | 4 | |a Breakthrough | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Delta | |
650 | 4 | |a Omicron | |
650 | 4 | |a Reinfection | |
700 | 1 | |a Bhatt, Puneet |e verfasserin |4 aut | |
700 | 1 | |a Sahay, Rima R |e verfasserin |4 aut | |
700 | 1 | |a Joshi, Yash |e verfasserin |4 aut | |
700 | 1 | |a Patil, Deepak Y |e verfasserin |4 aut | |
700 | 1 | |a Yadav, Pragya D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 85(2022), 1 vom: 25. Juli, Seite e15-e17 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:85 |g year:2022 |g number:1 |g day:25 |g month:07 |g pages:e15-e17 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2022.04.023 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 85 |j 2022 |e 1 |b 25 |c 07 |h e15-e17 |